Cargando…
Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?
Autores principales: | Batista, Marta Vaz, Perez-Gracia, José, Eiriz, Inês, Gion, Maria, Llombart, Antonio, Braga, Sofia, Cortés, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327813/ https://www.ncbi.nlm.nih.gov/pubmed/37417883 http://dx.doi.org/10.18632/oncotarget.28435 |
Ejemplares similares
-
Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity
por: Batista, Marta Vaz, et al.
Publicado: (2023) -
COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020) -
Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022) -
The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013) -
Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)